Highly phosphorylated inositol phosphates are the major inositol phosphates present in the cell (1) . Specifically, the intracellular concentration of D-myo-inositol 1,2,3,4,5,6-hexakisphosphate (InsP 6 ) reaches levels corresponding to 40-60 M in several cell types, including insulin-secreting cells (2) (3) (4) . In some cell types the concentration of these inositol polyphosphates can be rapidly altered upon cell stimulation (5, 6) .
Inositol polyphosphates may be involved in the control of several cellular functions (1) , one of which is regulation of vesicle trafficking, processes of endocytosis and vesicle recycling. D-myo-inositol 1,3,4,5-tetrakisphosphate, D-myo-inositol 1,3,4,5,6-pentakisphosphate (InsP 5 ) and InsP 6 bind to the C2B domain of synaptotagmin (7), a protein believed to be a main Ca 2ϩ -sensor in regulated exocytosis in neurons. The injection of inositol polyphosphates into squid giant synapse preterminal caused blocking of synaptic transmission, due to binding of injected compounds to the C2B domain of synaptotagmin (8) . Inositol polyphosphates binding to clathrin assembly proteins, adaptor proteins AP-2 (9), and AP-3 (10) inhibit clathrin assembly, suggesting the influence of the compounds upon vesicle trafficking (10) .
The aim of the present study was to evaluate a possible role for InsP 6 in the regulation of insulin exocytosis.
MATERIALS AND METHODS

Materials.
InsP 5 and InsP 6 were from CalbiochemNovabiochem. Streptolysin O was obtained from Difco. All other reagents were from Sigma.
Cell Culture. Hamster insulinoma tumor HIT T15 cells were cultured at 37ЊC in RPMI medium 1640 containing 11 mM glucose and supplemented with 10% (vol͞vol) heat-inactivated fetal calf serum, 2 mM glutamine, 100 g͞ml streptomycin, 100 units͞ml penicillin, 10 Ϫ7 M selenous acid, and 10 g͞ml glutathione, as described (11) . All experiments were carried out in HIT T15 cells of passage numbers between 73-80.
Cell Permeabilization and Measurements of Insulin Secretion. Two different procedures were used to permeabilize cells, namely permeabilization by electric field and streptolysin O-induced permeabilization. The permeabilization buffer consisted of 140 mM potassium glutamate, 5 mM NaCl, 1.2 mM MgCl 2 , 10 mM EGTA, 25 mM Hepes, 0.025% albumin (pH 7.0). For streptolysin O-induced permeabilization, 1 mM dithiothreitol was added to the buffer. The electropermeabilization and permeabilization with streptolysin O were performed as described (12, 13) .
Both types of permeabilization have their own benefits and drawbacks. Electropermeabilization creates only small holes in the plasma membrane, that prevents leakage of molecules Ͼ5 kDa from the cell. These holes reseal with time (14) . By contrast, cells permeabilized with streptolysin O are leaking not only small molecules but also large proteins. Cells permeabilized by this procedure do not reseal (15) . The use of one or the other of the procedures was dependent on the aim of each particular experiment.
Measurements of insulin secretion were performed in a permeabilization buffer containing additionally 2 mM MgATP and an ATP-regenerating system, 2 mM creatine phosphate, 10 unit͞ml creatine phosphokinase, and Ca 2ϩ concentrations in the range from 3 ϫ 10 Ϫ8 M to 1 ϫ 10 Ϫ5 M. Priming effects of InsP 6 on insulin secretion were measured as follows. Cells were treated with different concentrations of InsP 6 for 15 min in ATP-containing buffer and then insulin secretion was measured in ATP-free buffer without InsP 6 at 30 nM or at 10 M Ca 2ϩ during 15 min. Insulin content was determined by radioimmunoassay using rat insulin as a standard. din-coated filters. Incorporation of 32 P into biotinylated substrate was assessed by liquid scintillation counting.
Presentation of Results. Data analysis was performed using the program SIGMA PLOT 1.02 for Windows (Jandel, San Rafael, CA). All results are expressed as means Ϯ SEM for the indicated number of observations. Statistical significance of differences between means were assessed by Student's unpaired t test. Differences were considered significant at P Ͻ 0.05.
RESULTS
The effects of 20 M InsP 5 and 20 M InsP 6 on insulin secretion were tested at free Ca 2ϩ -concentrations ranging from 30 nM to 10 M in electropermeabilized HIT T15 cells (Fig. 1 ). Only at basal (30 nM) free Ca 2ϩ concentration, both compounds stimulated exocytosis of insulin. The stimulatory effect could not be detected at higher Ca 2ϩ -concentrations. Since InsP 6 is present at high concentrations in insulinsecreting cells (4), this inositol polyphosphate was chosen for the investigation of the mechanism underlying the stimulatory effects of inositol polyphosphates on insulin secretion.
Stimulation of non-Ca 2ϩ -mediated insulin secretion by InsP 6 was concentration-dependent and at 50 M InsP 6 , insulin release reached Ϸ150% of secretion obtained in the absence of inositol polyphosphate ( Fig. 2A) . The stimulatory effects of InsP 6 on insulin secretion could not be detected when the Ca 2ϩ -concentration was increased (Fig. 2B) . To check if the observed effects of InsP 6 were due to possible changes in free Ca 2ϩ -concentration induced by the compound, measurements of the ambient free Ca 2ϩ -concentration in the permeabilization buffer were performed (Fig. 2 C and D) . At a concentration of 20 M, InsP 6 did not alter resting Ca 2ϩ -concentration (30 nM) (Fig. 2C ). Under this condition 50 M of InsP 6 only reduced resting Ca 2ϩ -concentration by 20%. InsP 6 (20 and 50 M) decreased stimulating Ca 2ϩ -concentration not more than 7-10% (Fig. 2D ). Although InsP 6 has a well-documented ability to chelate Ca 2ϩ -ions (16), the Ca 2ϩ -buffers used in this study have enough capacity to prevent significant changes in free Ca 2ϩ -concentration in the presence of InsP 6 . Another Ca 2ϩ -chelator, 100 M EGTA, added to the incubation buffer produced analogous slight decrease in free Ca 2ϩ -concentration but did not significantly affect insulin secretion measured at 30 nM Ca 2ϩ (data not shown). Thus, the effects of InsP 6 on insulin secretion cannot be accounted for by changes in the free Ca 2ϩ -concentration.
InsP 6 is not the last member in the array of inositol polyphosphates. Higher phosphorylated inositol polyphosphate pyrophosphates, PP-InsP 5 and (PP) 2 -InsP 4 , formed from InsP 6 and InsP 5 , have also been described (17) . It has been proposed that inositol polyphosphate pyrophosphates are intracellular energy stores because of the high energy hydrolysis of pyrophosphoryl residues (18) . Therefore, we tested the specificity of the effect of InsP 6 on exocytosis. The process of formation of pyrophosphates can be activated by NaF, through the inhibition of phosphatases responsible for pyrophosphate dephosphorylation (17) . Addition of 5 mM NaF, this concentration maximally increased PP-InsP 5 concentration but did not significantly activate G-proteins (17) , instead of increasing slightly decreased InsP 6 -stimulated insulin release (139 Ϯ 3% increase in secretion with 50 M InsP 6 vs. 127 Ϯ 2% with 50 M InsP 6 and NaF, 15 observations from three separate experiments). This supports the suggestion that InsP 6 rather than PP-InsP 5 or (PP) 2 -InsP 4 stimulated exocytosis.
One of the reported effects of inositol polyphosphates, is activation of PKC isoenzymes as well as the PKC-related kinase, PRK1 (19) . The kinase activation was observed only in a Ca 2ϩ -free medium and at inositol polyphosphate concentrations similar to those that stimulated insulin secretion in our experiments. Therefore, we examined the possibility that stimulation of exocytosis by inositol polyphosphates can be explained by activation of PKC. In HIT T15 cells, 50 M InsP 6 activated PKC in the absence of free Ca 2ϩ and did not significantly affect Ca 2ϩ -induced activation of the enzyme (Fig. 3A) .
The selective inhibitor of PKC, Calphostin C (1.5 M) abolished stimulation of insulin secretion by 50 M InsP 6 (Fig.  3B) . To confirm that protein kinase activation is involved in the stimulatory effect of InsP 6 on insulin secretion, experiments substituting ATP with its non-hydrolyzable analog ␤,␥-methyleneadenosine 5Ј-triphosphate (AMP-PCP), which cannot serve as a substrate for protein kinase-induced phosphorylation, were performed. AMP-PCP blocked InsP 6 -induced exocytosis (Fig. 3C) . Finally, 1 M okadaic acid, an inhibitor of protein phosphatases type 1, 2A, and 3 (20) , potentiated the effect of 50 M InsP 6 on insulin release, whereas 100 nM 12-O-tetradecanoylphorbol 13-acetate (TPA), a potent activator of PKC, did not (Fig. 3D ). This suggests that activation of PKC rather than inhibition of protein phosphatases is responsible for the stimulation of exocytosis by InsP 6 . Experiments presented so far described acute effects of InsP 6 on non-Ca 2ϩ -mediated insulin exocytosis. To evaluate possible effects of InsP 6 on Ca 2ϩ -mediated exocytosis, cells were preincubated with the inositol polyphosphate in the absence of Ca 2ϩ and subsequently stimulated with high concentrations of the ion. We have employed streptolysin O-permeabilized cells for this type of experiments, since the stability of the formed holes in the plasma membrane during prolonged time of incubation was essential. Permeabilized cells were first incubated in a buffer containing ATP, an ATP-regenerating system, 30 nM Ca 2ϩ , and different concentrations of InsP 6 . This buffer was replaced by a buffer containing 30 nM or 10 M Ca 2ϩ without InsP 6 and ATP. Insulin content in the latter buffer was measured. Changing of permeabilization procedure did not perturb the ability of InsP 6 to affect insulin exocytosis. InsP 6 (20 and 50 M) also primed non-Ca 2ϩ -mediated exocytosis (Fig. 4A) . The effect of InsP 6 on Ca 2ϩ -mediated exocytosis was pronounced. In this case, both 20 M and 50 M of the compound stimulated insulin secretion by 45% (Fig. 4B ). Calphostin C (1.5 M) suppressed insulin secretion induced by 50 M InsP 6 (Fig. 4C) .
DISCUSSION
Permeabilized insulin-secreting cells were used to investigate a possible role for InsP 6 in regulated exocytosis. InsP 6 stimulated non-Ca 2ϩ -mediated and primed Ca 2ϩ -mediated exocytosis of insulin, effects mediated through the activation of PKC. The involvement of PKC was verified by experiments showing that the InsP 6 effect was blocked with Calphostin C and substitution of ATP with the non-hydrolyzable analog AMP-PCP. The potentiation of insulin secretion by InsP 6 in the presence of 1 M okadaic acid, a concentration known to inhibit protein phosphatases type 1, 2A, and 3 (20) , suggests that the observed stimulatory activity of InsP 6 on insulin release cannot be explained by an inhibitory activity of the compound on these protein phosphatases. Activation of PKC by InsP 6 in insulin-secreting cells, in the absence of Ca 2ϩ , is consistent with the data that InsP 6 , at concentrations higher than 20 M, activates several isoenzymes of PKC as well as PKC-related kinase (19) .
Processes of protein phosphorylation play a central role in the regulation of exocytosis in the pancreatic ␤-cell (21, 22) . Activation of PKC by InsP 6 may lead to increased availability of releasable secretory granules, by promoting the recruitment and transport of granules to the site of exocytosis. The increasing amount of granules associated with the plasma membrane and ready-to-fuse would lead to the subsequent increase in insulin exocytosis. In addition, InsP 6 may directly affect granule fusion since the conformation of proteins responsible for fusion events in exocytosis could be controlled by PKC activity (23, 24) .
The fact that the stimulatory effect of InsP 6 on insulin exocytosis disappeared at elevated Ca 2ϩ -concentrations, may be explained by the conversion of InsP 6 into the inactive Ca 2ϩ -bound form, each molecule of InsP 6 binding two or three Ca 2ϩ -ions (16) . Such a conversion is in agreement with what has previously been suggested in the context of the disappearance of the stimulatory effect of inositol hexakisphosphate on PKC activity at high concentrations of Ca 2ϩ (19) . In the latter study, the authors suggested that the negative charge of phosphate groups plays a significant role in the effects of InsP 6 .
As discussed above, InsP 6 readily chelates Ca 2ϩ -ions. This complicates any investigation of the role of the compound in Ca 2ϩ -mediated exocytosis. We have separated in time the preincubation of cells with InsP 6 in ATP-containing medium and subsequent incubation of cells in the buffer containing high Ca 2ϩ -concentration in the absence of ATP and InsP 6 . The results obtained show that in HIT T15 cells Ca 2ϩ triggers exocytosis of insulin in an ATP-independent manner, as described before for exocytosis of biogenic amines in PC12 cells (25) (26) (27) . By applying this type of incubation procedure, we found that preincubation with InsP 6 led to a markedly pronounced stimulatory effect on Ca 2ϩ -induced insulin exocytosis. It is likely that InsP 6 under these conditions potentiated insulin release by priming Ca 2ϩ -mediated fusion of secretory granules with the plasma membrane. Hence, inositol polyphosphates may keep granule transport active under basal conditions and thereby increasing the number of granules available at the site of exocytosis, explaining both the stimulatory effect of InsP 6 on non-Ca 2ϩ -mediated-and the priming of Ca 2ϩ -mediated insulin release (Fig. 5) . Intracellular levels of inositol polyphosphates vary, being particularly high in several cell types like the insulin-secreting cell. By influencing the rates of InsP 6 synthesis and conversion, InsP 6 concentration may be rapidly changed, which should in turn give rise to modulation of insulin exocytosis. We have shown that InsP 6 , in a physiological concentration range, is able to modulate exocytosis. At 20-50 M concentrations, this compound stimulated insulin secretion at basal Ca 2ϩ -concentration and primed Ca 2ϩ -mediated exocytosis. Both effects of InsP 6 were dependent on the activation of PKC. This suggests that inositol polyphosphates can function as signaling molecules in stimulus-secretion coupling in pancreatic ␤-cells.
FIG. 5. Scheme illustrating the role of InsP6 in insulin exocytosis.
A denotes an intracellular pool of insulin containing granules that are not activated for fusion, and B denotes a pool of granules close to the plasma membrane that undergoes Ca 2ϩ -activated fusion. The exocytotic process of insulin can thus be separated into ATP-dependent vesicle priming and ATP-independent Ca 2ϩ -activated fusion. According to the scheme the rate of insulin secretion is determined by the amount of primed vesicles and the probability of the fusion event for each granule. Through activation of PKC, InsP6 may influence both of these steps of insulin secretion. Hence, the processes discussed in this paper may be presented in the following way. (i) Insulin secretion at resting Ca 2ϩ concentration and in the absence of InsP6. Insulin release is restricted by the amount of primed vesicles and a low probability of vesicle fusion at resting Ca 2ϩ concentration.
(ii) Activation of insulin secretion at resting Ca 2ϩ concentration by InsP6. InsP6 activates PKC, which leads to an increased priming of secretory vesicles and maybe in addition direct activation of the fusion process. Modest stimulation of insulin release is observed relative to i. (iii) Ca 2ϩ -induced exocytosis in the absence of InsP6. Probability of vesicle fusion is high. It gives rise to a pronounced stimulation of insulin secretion, but the stimulation is still not maximal and limited by the availability of primed vesicles. (iv) Priming of Ca 2ϩ -induced exocytosis by InsP6. Similar to ii, InsP6 increased priming of secretory vesicles, an effect mediated by PKC activation. A high probability of vesicle fusion together with an increased amount of vesicles at the site of exocytosis lead to pronounced insulin secretion.
